Spots Global Cancer Trial Database for uterine hemorrhage
Every month we try and update this database with for uterine hemorrhage cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety of Treatment of Uterine Fibroids With Asoprisnil | NCT00156208 | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroid... | Asoprisnil Asoprisnil | 18 Years - | Abbott | |
| A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas | NCT02147158 | Leiomyoma Uterine Hemorrh... | Ulipristal acet... Placebo | 18 Years - 50 Years | Allergan | |
| Safety of Treatment of Uterine Fibroids With Asoprisnil | NCT00156208 | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroid... | Asoprisnil Asoprisnil | 18 Years - | Abbott | |
| A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids | NCT00152256 | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroid... | Asoprisnil Asoprisnil Placebo | 18 Years - 53 Years | Abbott | |
| A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas | NCT02147158 | Leiomyoma Uterine Hemorrh... | Ulipristal acet... Placebo | 18 Years - 50 Years | Allergan | |
| Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids | NCT00156195 | Leiomyoma Menorrhagia Metrorrhagia | Asoprisnil Asoprisnil | 18 Years - | Abbott | |
| HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding | NCT04867109 | Endometrial Neo... Postmenopause Uterine Hemorrh... Cancer Biomarke... CA 125 Antigen | Patients with P... CA125 and HE4 a... | 18 Years - | Nantes University Hospital | |
| A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas | NCT02147158 | Leiomyoma Uterine Hemorrh... | Ulipristal acet... Placebo | 18 Years - 50 Years | Allergan | |
| A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas | NCT02147197 | Leiomyoma Uterine Hemorrh... | Ulipristal acet... Placebo | 18 Years - 50 Years | Allergan | |
| Study of Asoprisnil in the Treatment of Uterine Fibroids. | NCT00156156 | Fibroid Uterus Leiomyoma Menorrhagia Metrorrhagia Uterine Fibroid... | Asoprisnil Asoprisnil | 18 Years - | Abbott | |
| Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids | NCT00156195 | Leiomyoma Menorrhagia Metrorrhagia | Asoprisnil Asoprisnil | 18 Years - | Abbott | |
| A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids | NCT00160381 | Leiomyoma Menorrhagia Metrorrhagia | Asoprisnil Asoprisnil Placebo | 18 Years - | Abbott |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
